This is the authors' abstract. We don't add key points for this paper.
Lung infections with nontuberculous mycobacteria (NTM), and particularly Mycobacterium abscessus, a pathogen with high antibiotic resistance, are of great concern due to poor clinical outcomes and challenging detection in people with cystic fibrosis and other diseases. Standard detection methods are insensitive and increasingly difficult. We describe the measurement of NTM-specific antibodies from plasma to identify subjects infected with M. abscessus. The assay is sensitive and provides information on the immune response to NTM infections. This assay could be used to help identify subjects with NTM pulmonary infections and track disease progression, either alone or in conjunction with other tests.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Malcolm et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: